Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children

Pediatric Infectious Disease Journal

Volumn 26, Issue 1, 2007, Pages 53-60

  Chantry, Caroline J ^a,l   Frederick, Margaret M ^b   Meyer III, William A ^c   Handelsman, Edward ^d   Rich, Kenneth ^e   Paul, Mary E ^f   Diaz, Clemente ^g   Cooper, Ellen R ^h   Foca, Marc ⁱ   Adeniyi Jones, Samuel K ^j   Moye, Jack ^k  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Clinical Trials & Surveys Corp   (United States)

^c QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

^e UNIVERSITY OF ILLINOIS   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^h BOSTON MEDICAL CENTER   (United States)

ⁱ Department of Orthopaedic Surgery   (United States)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^k EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Body composition; Children; Cortisol; DHEA; Growth; Growth hormone; HIV; Insulin like growth factor binding protein 3; Thyroid

Indexed keywords

GROWTH HORMONE; HYDROCORTISONE; PRASTERONE; SOMATOMEDIN BINDING PROTEIN 2; THYROID HORMONE;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY COMPOSITION; BODY GROWTH; BODY HEIGHT; BODY MASS; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE DISEASE; ENDOCRINE SYSTEM EXAMINATION; FEMALE; GROWTH RETARDATION; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; PHYSICAL DEVELOPMENT; PRIORITY JOURNAL; SCORING SYSTEM;

BODY HEIGHT; BODY WEIGHT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DEHYDROEPIANDROSTERONE; FEMALE; HIV INFECTIONS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; THYROID GLAND; TRIIODOTHYRONINE;

EID: 33845992230     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000247131.76584.af     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention, Divisions of HIV/AIDS Prevention. Pediatric HIV/AIDS surveillance: AIDS-defining conditions most commonly reported for children <13 years of age, reported through 2001, United States. Available at: http://www.cdc.gov/hiv/graphics/pediatr.htm. Accessed November 19, 2004.
2. Moye J Jr, Rich KC, Kalish LA, et al. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus: Women and Infants Transmission Study Group. J Pediatr. 1996;128:58-69.
3. Bobat R, Coovadia H, Moodley D, Coutsoudis A, Gouws E. Growth in early childhood in a cohort of children born to HIV-1-infected women from Durban, South Africa. Ann Trop Paediatr. 2001;21:203-210.
4. Saavedra JM, Henderson RA, Perman JA, Hutton N, Livingston RA, Yolken RH. Longitudinal assessment of growth in children born to mothers with human immunodeficiency virus infection. Arch Pediatr Adolesc Med. 1995;149:497-502.
5. Chantry C, Byrd R, Englund J, Baker C, McKinney R, PACTG 152 Team. Growth, survival and viral load in childhood HIV infection. Pediatr Infect Dis J. 2003;22:1033-1039.
6. Buchacz K, Cervia JS, Lindsey JC, et al, for the Pediatric AIDS Clinical Trials Group 219 Study Team. Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children. Pediatrics. 2001;108:e72.
7. Verweel G, van Rossum AMC, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type-1-infected children is associated with a sustained effect on growth. Pediatrics. 2002;109:e25.
8. Miller TL, Mawn BE, Orav EJ, et al. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics. 2001;107:e77.
9. Dremaine D, Nielsen K, Deveikis A, Bryson YJ, Geffner ME. Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J. 2001;20:315-316.
10. Nachman SA, Lindsey JC, Pelton S, et al. Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy. Arch Pediatr Adolesc Med. 2002;156:497-503.
11. Chiarelli F, Galli L, Verrotti A, diRocco L, Vierucci A, de Martino M. Thyroid function in children with perinatal human immunodeficiency virus type 1 infection. Thyroid. 2000;10:499-505.
12. Laue L, Pizzo PA, Butler K, Cutler GB Jr. Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome. J Pediatr. 1990;117:541-545.
13. Jospe N, Powell KR. Growth hormone deficiency in an 8-year old girl with human immunodeficiency virus infection. Pediatrics. 1990;86:309-312.
14. Cieslak TJ, Ascher DP, Zimmerman PA, et al. Adrenal insufficiency presenting as HIV wasting syndrome in a child: initial successful response to megestrol. Pediatr AIDS HIV Infect. 1991;2:279-283.
15. Frost RA, Nachman SA, Lang CH, Gelato MC. Proteolysis of insulin-like growth factor-binding protein-3 in human immunodeficiency virus-positive children with failure to thrive. J Clin Endocrinol Metab. 1996;81:2957-2962.
16. Ratner Kaufman F, Gerner JM, Sleeper LA, Donfield SM. Growth hormone secretion in HIV-positive versus HIV-negative hemophilic males with abnormal growth and pubertal development: the Hemophilia Growth and Development Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:137-144.
17. Rondanelli M, Caselli D, Arico M, et al. Insulin-like growth factor I (IGF-I) and IGF-binding protein 3 response to growth hormone is impaired in HIV-infected children. AIDS Res Hum Retroviruses. 2002;18:331-339.
18. Rondanelli M, Caselli D, Maccabruni A, et al. Involvement of hormonal circadian secretion in the growth of HIV-infected children. AIDS. 1998;12:1845-1850.
19. Vigano A, Mora S, Brambilla P, et al. Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents. AIDS. 2003;17:1435-1441.
20. Rana S, Nunlee-Bland G, Valyasevi R, Ibqal M. Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial? Pediatr AIDS HIV Infect. 1996;7:424-428.
21. Chantry C, Febo I, Gonzalez de Pijem L, Lugo L. Adrenal insufficiency secondary to megestrol acetate therapy in HIV-infected children. Int Conf AIDS. 1998;12:610-611. Abstract no. 32445.
22. Rondanelli M, Caselli D, Trotti R, et al. Endocrine pancreatic dysfunction in HIV-infected children: association with growth alterations. J Infect Dis. 2004;190:908-912.
23. Reitschel P, Hadigan C, Corcoran C, et al. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy. J Clin Endocrinol Metab. 2001;86:504-510.
24. Abbott M, Khoo SH, Hammer MR, Wilkins EG. Prevalence of cortisol deficiency in late HIV disease. J Infect. 1995;31:1-4.
25. Christeff N, Melchior JC, Mammes O, Gherbi N, Dalle MT, Nunez EA. Correlation between increased cortisol:DHEA ratio and malnutrition in HIV-positive men. Nutrition. 1999;15:534-539.
26. Carey VJ, Yong FH, Frenkel LM, McKinney RE Jr. Pediatric AIDS prognosis using somatic growth velocity. AIDS. 1998;12:1361-1369.
27. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. 2000 CDC growth chart training modules and resources: training using the BMI-for-age growth charts: module 1. Available at: http://www.cdc.gov/nccdphp/dnpa/growthcharts/training/modules/ module1/text/module1print.pdf. Accessed June 7, 2005.
28. Freedman DS, Wang J, Maynard LM, et al. Relation of BMI to fat and fat-free mass among children and adolescents. Int J Obes Relat Metab Disord. 2005;29:1-8.
29. Grinspoon S, Corcoran C, Stanley T, Rabe J, Wilkie S. Mechanisms of androgen deficiency in human immunodeficiency virus-infected women with the wasting syndrome. J Clin Endocrinol Metab. 2001;86:4120-4126.
30. Moye J, Frederick M, Chantry C, et al, for the Women and Infants Transmission Study (WITS). 10-Year follow-up of somatic growth in children born to women infected by human immunodeficiency virus (HIV). Eighth Conference on Retroviruses and Opportunistic Infections; Chicago, IL; February 4-8, 2001. Abstract No. 514.
31. Panamonta O, Kosalaraksa P, Thinkhamrop B, Kirdpon W, Ingchanin C, Lumbiganon P. Endocrine function in Thai children infected with human immunodeficiency virus. J Pediatr Endocrinol Metab. 2004;17:33-40.
32. Hommes MJ, Romijn JA, Enderte E, Adriaanse R, Brabant G, Schattenkertk E. Hypothyroid-like regulation of the pituitary-thyroid axis in stable human immunodeficiency virus infection. Metabolism. 1993;42:556-561.
33. Koutkia P, Mylonakis E, Levin RM. Human immunodeficiency virus infection and the thyroid. Thyroid. 2002;12:577-582.
34. Guercio G, Rivarola MA, Chaler E, Maceiras M, Belgorosky A. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. J Clin Endocrinol Metab. 2003;88:1389-1393.